Trilaciclib Prior to Chemotherapy Plus Tislelizumab as 1L Treatment for Advanced Squamous Non-Small-Cell Lung Cancer

NCT05900921 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Advanced Squamous Non-Small-Cell Lung Cancer

Interventions

DRUG: Trilaciclib
DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Tislelizumab

Sponsor

Sichuan University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]